Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ · Healthcare
Vanda Pharmaceuticals Inc. Operating Income 2009–2025
Vanda Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Vanda Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -50.2 M, a 22.41% increase year-over-year.
- Vanda Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -161.0 M, a 342.71% increase year-over-year.
- Vanda Pharmaceuticals Inc. annual operating income for 2025 was -151.2 M, a 271.79% increase from 2024.
- Vanda Pharmaceuticals Inc. annual operating income for 2024 was -40.7 M, a 191.43% increase from 2023.
- Vanda Pharmaceuticals Inc. annual operating income for 2023 was -14.0 M, a 320.45% decrease from 2022.
- Vanda Pharmaceuticals Inc. annual operating income for 2022 was 6.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vanda Pharmaceuticals Inc. Operating Income — FAQ
Vanda Pharmaceuticals Inc. (VNDA) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Vanda Pharmaceuticals Inc.'s operating income?
Vanda Pharmaceuticals Inc. (VNDA) reported operating income of -$151M for fiscal 2025.
Where can I see VNDA's operating income history?
The chart and table above show Vanda Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.